Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Revolution Medicines, Inc. Stock Price: Quote, Financials, Forecast & News (RVMD)

Markets open

Revolution Medicines, Inc.

RVMD · Nasdaq

Overview Financials Earnings Holders Historical Data Analysis

Symbol: RVMD
Type: Stock
Sector: Health Care
Industry: Biotechnology: Biological Products (No Diagnostic Substances)
Country: North America
Exchange: Nasdaq

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Additional development opportunities in the company's pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).

Analyst Consensus

Buy

13 analysts

$195

Current

—

Low

$210

Average

—

High

Average target implies +7.89% versus the current price.

Earnings History

BeatMissNo estimate

Peers

IDEXX Laboratories, Inc.IDXX · Nasdaq

$592.760.79%

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share ofTAK · NYSE$16.590.18%

argenx SE American Depositary SharesARGX · Nasdaq$870.283.05%

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series ABRKRP · Nasdaq$390.872.82%

$194.65+$0.870.45%

As of: Aug 5, 2:37 PM

Prev Close: $193.46
Market Cap: $41.38B
Open: —
Trailing P/E: —
Day Range: $198.30 - $194.03
52W Range: $194.56 - $34.00
Forward P/E: —
EPS: —
Volume: 362.07K
Dividend Yield: —

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy?

The Motley Fool · 2d ago

Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock

The Motley Fool · 3d ago

Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now

The Motley Fool · Jul 29

FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer

Zacks · Jul 23

Revolution Medicines' NDA For Daraxonrasib Accepted By FDA For Metastatic Pancreatic Cancer

RTTNews · Jul 23 Noteworthy ETF Outflows: SCHA, LITE, RVMD, MTSI

BNK Invest · Jul 21 This Stock Has Skyrocketed 125% in 2026 -- and Billionaire Stanley Druckenmiller Is Loading Up on It

The Motley Fool · Jul 17 Better Growth Buy: Axsome vs Revolution Medicines

The Motley Fool · Jul 9

Beta

—

Avg Volume

2.73M